Navigation Links
Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
Date:4/29/2009

First-Quarter 2009 Highlights:

- GAAP diluted EPS increased 16.0 percent to $0.58 from $0.50 in first-quarter 2008

- Diluted EPS, excluding $0.05 in amortization of intangible assets from the 2003 spin-off, increased 14.5 percent to $0.63 from $0.55 in first-quarter 2008

- Total net revenues increased 14.4 percent to a record $14.8 billion

- Specialty pharmacy revenues increased 21.0 percent to a record $2.3 billion

- Generic dispensing rate increased 3.5 percentage points to a record 66.8 percent

- Cash flow from operations increased 7-fold to a record of nearly $1.2 billion

2009 Guidance Reaffirmed:

- Full-year 2009 GAAP diluted EPS expected in the range of $2.45 to $2.55, representing 15 to 20 percent growth over 2008

- Full-year 2009 diluted EPS, excluding amortization of intangible assets, expected in the range of $2.67 to $2.77, representing 15 to 19 percent growth over 2008

FRANKLIN LAKES, N.J., April 29 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) today reported first-quarter 2009 GAAP diluted earnings per share of $0.58, up 16.0 percent compared to $0.50 for the first quarter of 2008. Adjusting for the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, first-quarter 2009 diluted earnings per share increased 14.5 percent to $0.63, from $0.55 in the first quarter of 2008. With continuing strength across its operations and confident in its continued ability to deliver value-driven solutions to its clients in a weakened economy, Medco reaffirmed its 2009 earnings guidance, projecting GAAP diluted EPS growth of 15 to 20 percent over 2008.

"Our solid first-quarter results reflect our success at growing our t
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related biology technology :

1. Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value
2. Medco to Present at the Deutsche Bank 33rd Annual Health Care Conference
3. Medco Issues $1.5 Billion of Senior Notes
4. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
5. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
6. Medco to Webcast Annual Analyst Day Conference
7. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
8. Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
9. Fat droplet nanoparticle delivers tumor suppressor gene to tumor and metastatic cells
10. Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
11. ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/v6klp2/nanobiotechnology ... PharmaBiotech,s new report "Nanobiotechnology Applications, Markets ... An increasing use of nanobiotechnology ... anticipated. Nanotechnology will be applied at all ... for optimal delivery to diagnostic applications in ...
(Date:9/2/2015)... Research and Markets ... Jain PharmaBiotech,s new report "DNA Sequencing - ... This report briefly reviews basics of ... their applications. Current large and small sequencers are ... applications of sequencing are described including those for ...
(Date:9/2/2015)... ... September 02, 2015 , ... The wet form of ... special anti-vascular endothelial growth factor agents given by injection into the eye. Dry ... a scientific protocol for the many millions diagnosed with it. AMD usually starts ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cqsxmg/gene_therapy ) ... "Gene Therapy - Technologies, Markets and Companies" ... therapy are difficult to estimate as there is only ... in China since 2004. Gene ... estimates are based on epidemiology of diseases to be ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2
... just escaped January a notoriously depressing month because ... dank weather thats no surprise. In fact, an ... ago) was the most depressing day of the year. ... burden because of the challenges they face, their depression ...
... A biotech company moving to Madison from Chicago is ... the state. , ,Governor Jim Doyle announced earlier this ... $135,000 from the Department of Commerce Technology Venture ... (TAG) programs to help the company purchase new equipment ...
... Madison-based lab that studies learning technologies with the University of Wisconsin ... Thursday evening at the World Futurist Society meeting . The ... experience at the Academic Advanced Distributed Learning Co-Lab , Brown ... is looking to video games as a teaching tool. Read more. ...
Cached Biology Technology:Post-January, tech entrepreneurs have reasons to be depressed 2Post-January, tech entrepreneurs have reasons to be depressed 3Post-January, tech entrepreneurs have reasons to be depressed 4Tech Digest: Futurists on learning; Sonic Foundry; Accu Tech; Fiserv 2
(Date:8/24/2015)... 2015 The consulting company Frost & ... manufacturer DERMALOG and its customized solutions and products for ... of the Year Award". DERMALOG is particularly successful with a ... -Cross reference: Picture is available at AP Images ... On Thursday evening, in South Africa,s ...
(Date:8/20/2015)... CLARA, Calif. , Aug. 20, 2015 /PRNewswire/ ... company focused on improving the user experience and ... and vision technologies, today announced that its ... voice biometric authentication software to be FIDO ... tested TrulySecure for compliance with the FIDO UAF ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas ... key contributor to the Submission Content Management ... IRISS, a non-profit forum. Dedicated to the Implementation ... a neutral platform for industry, vendors, health ... information and work towards a standard method ...
Breaking Biology News(10 mins):Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
... show a combination of depressive symptoms and elevated levels of ... likely to develop major depression than those who show neither ... In a study published today in the Proceedings ... University of Cambridge have identified the first biomarker a ...
... non-coding RNAs can be used to predict if individuals ... Cancer Genome Atlas project. The results, which are published ... the levels of specific types of non-coding RNAs can ... These RNAs can also be used to classify cancer ...
... cancers so difficult to treat is that malignant cells from ... and blood vessels to invade new locations. Now, researchers have ... cancer by using a film of nanofibers thinner than human ... invading new areas, the migrating cells latch onto the specially-designed ...
Cached Biology News:First biological marker for major depression could enable better diagnosis and treatment 2First biological marker for major depression could enable better diagnosis and treatment 3First biological marker for major depression could enable better diagnosis and treatment 4Small non-coding RNAs could be warning signs of cancer 2Researchers hijack cancer migration mechanism to 'move' brain tumors 2Researchers hijack cancer migration mechanism to 'move' brain tumors 3Researchers hijack cancer migration mechanism to 'move' brain tumors 4
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient...
... utilize the membrane-permeant ester forms (CCF2-AM ... fluorescent beta-lactamase substrates, CCF2 and CCF4. ... cell, where cleavage by endogeneous cytoplasmic ... negatively charged forms, thereby trapping them ...
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient vir...
... utilize the membrane-permeant ester forms (CCF2-AM ... fluorescent beta-lactamase substrates, CCF2 and CCF4. ... cell, where cleavage by endogeneous cytoplasmic ... negatively charged forms, thereby trapping them ...
Biology Products: